HADLIMA (This drug is a biosimilar to Humira®)
Injection under the skin (subcutaneous)
Moderate to severe Crohn's disease and ulcerative colitis
Recommendations for Pregnancy
Effects to fetus are unknown
Recommendations for Lactation
Present in breast milk; talk to your doctor
Indicated for the treatment of adults with moderately-to-severely active Crohn's disease and ulcerative colitis
Indicated for pediatric use
Most common side effects
Common side-effects include injection site reactions such as redness, rash, swelling, itching, pain, or bruising; upper respiratory infections (including sinus infections); headaches, rash, nausea. Rare side effects include lupus-like syndrome.
Serious infections have included tuberculosis (TB) and infections caused by viruses, fungi. Lupus-like reactions, and liver problem are rare but have also been reported. Another rare risk is cancer known as hepatosplenic T-cell lymphoma.
Scroll right by clicking & dragging with your cursor or swiping with your finger.